Literature DB >> 22026522

CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?

Gavin Bart1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22026522      PMCID： PMC3770269          DOI： 10.1080/10550887.2011.610707

Source DB:  PubMed          Journal:  J Addict Dis        ISSN： 1055-0887


× No keyword cloud information.
  24 in total

1.  Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.

Authors:  Einat Peles; Gershon Bodner; Mary Jeanne Kreek; Vera Rados; Miriam Adelson
Journal:  Addiction       Date:  2007-02       Impact factor: 6.526

2.  Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.

Authors:  Georg B Ehret; Cathy Voide; Marianne Gex-Fabry; Jocelyne Chabert; Dipen Shah; Barbara Broers; Valérie Piguet; Thierry Musset; Jean-Michel Gaspoz; Arnaud Perrier; Pierre Dayer; Jules A Desmeules
Journal:  Arch Intern Med       Date:  2006-06-26

3.  Acute opiate overdose: a preliminary report on mechanisms of death.

Authors:  M H Greene; J L Luke; R L DuPont
Journal:  Proc Natl Conf Methadone Treat       Date:  1973

4.  Impact of methadone treatment on cardiac repolarization and conduction in opioid users.

Authors:  Bridget A Martell; Julia H Arnsten; Mori J Krantz; Marc N Gourevitch
Journal:  Am J Cardiol       Date:  2005-04-01       Impact factor: 2.778

5.  QTc interval prolongation in patients on long-term methadone maintenance therapy.

Authors:  Icro Maremmani; Matteo Pacini; Claudio Cesaroni; Mercedes Lovrecic; Giulio Perugi; Alessandro Tagliamonte
Journal:  Eur Addict Res       Date:  2005       Impact factor: 3.015

6.  Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers.

Authors:  C B Eap; S Crettol; J-S Rougier; J Schläpfer; L Sintra Grilo; J-J Déglon; J Besson; M Croquette-Krokar; P-A Carrupt; H Abriel
Journal:  Clin Pharmacol Ther       Date:  2007-02-28       Impact factor: 6.875

7.  QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.

Authors:  Ellen C Pearson; Raymond L Woosley
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-11       Impact factor: 2.890

8.  QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.

Authors:  Erich F Wedam; George E Bigelow; Rolley E Johnson; Paul A Nuzzo; Mark C P Haigney
Journal:  Arch Intern Med       Date:  2007-12-10

9.  Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience).

Authors:  R J Goldberg; J Bengtson; Z Y Chen; K M Anderson; E Locati; D Levy
Journal:  Am J Cardiol       Date:  1991-01-01       Impact factor: 2.778

10.  Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.

Authors:  Søren Fanoe; Christian Hvidt; Peter Ege; Gorm Boje Jensen
Journal:  Heart       Date:  2007-03-07       Impact factor: 5.994
View more
  4 in total

Review 1.  Maintenance medication for opiate addiction: the foundation of recovery.

Authors:  Gavin Bart
Journal:  J Addict Dis       Date:  2012

2.  QTc interval screening in an opioid treatment program.

Authors:  David F Katz; Jun Sun; Vaishali Khatri; David Kao; Becki Bucher-Bartelson; Carol Traut; John Lundin-Martinez; Michael Goodman; Philip S Mehler; Mori J Krantz
Journal:  Am J Cardiol       Date:  2013-06-29       Impact factor: 2.778

3.  Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.

Authors:  Yi Zheng; Samuel Obeng; Huiqun Wang; Abdulmajeed M Jali; Bharath Peddibhotla; Dwight A Williams; Chuanchun Zou; David L Stevens; William L Dewey; Hamid I Akbarali; Dana E Selley; Yan Zhang
Journal:  J Med Chem       Date:  2019-01-11       Impact factor: 7.446

4.  Methadone and the QTc Interval: Paucity of Clinically Significant Factors in a Retrospective Cohort.

Authors:  Gavin Bart; Zachary Wyman; Qi Wang; James S Hodges; Rehan Karim; Bradley A Bart
Journal:  J Addict Med       Date:  2017 Nov/Dec       Impact factor: 3.702
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.